Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV03 in Dry Eye Disease Associated with MGD (Gobi)
NCT04139798Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perfluorohexyloctane in dry eye disease (DED), sponsored by Bausch + Lomb. Started Jul 2020; status: completed.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT04139798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139798.